Part of About Rory. Where Rory Riggs’s own writing, interviews, and professional profiles live on the public record.
Published writing
The Journal of Index Investing — “An Index Methodology for Diversifying Business Risk,” with Jonathan Chandler and Mark T. Finn, Vol. 8, No. 3, Winter 2017
Practical Applications — “Practical Applications of An Index Methodology for Diversifying Business Risk,” with Jonathan Chandler and Mark T. Finn, Vol. 6, No. 2, 2018
Pensions & Investments — “Systems Economics: A New Prescription for Risk Management,” July 15, 2019
Future Farming — “Gene Editing to Lead a New Agricultural Revolution,” author page
Interviews
Bloomberg Businessweek — “The Evolution of Gene-Edited Crops,” with Carol Massar and Madison Mills, July 7, 2023
RIA Channel — “Syntax: Riggs on Stratified Weighting,” with Julie Cooling, June 3, 2019
Rory Riggs is an inventor, executive, and investor who applies one system, the Locus Model, across biotechnology, finance, and economics. Mr. Riggs is Executive Chairman of Syntax Data, which has built a foundational coordinate-based information infrastructure for finance and economic data based on his patented Locus Model and Functional Information System (FIS).
A Work Locus describes what an entire Economic System does; a Resource Locus describes what one specific resource does — same syntax, different subject.
Gallery
Primary Headshots
Rory Riggs is an inventor, executive, and investor who applies one system, the Locus Model, across biotechnology, finance, and economics.
Co-founder and CEO of Cibus, the leading precision gene-editing company for agriculture. Applied the Locus Model's functional-systems approach to plant biology through the Rapid Trait Development System (RTDS).
Founded Locus Analytics in 2009 as an economic research firm to pioneer Systems Economics and develop and patent the Functional Information System. Syntax and Locus Analytics merged in March 2023. Built the coordinate-based Locus Model and FIS information infrastructure for finance and economic data, and the Syntax Stratified Indices.
Co-founded Royalty Pharma in 1996 with a $60 million start; built it into the world's largest acquirer of pharmaceutical royalties, holding partial royalty rights on seven of the top thirty drugs sold in the United States. Served as Chairman from 2003 and resigned as a director on June 6, 2024.
Inventor of the coordinate-based Locus Model and Functional Information System for classifying economic activity by function rather than conventional industry category.
Pharmaceutical royalty finance
Expert
Founded and built Royalty Pharma into the world's largest acquirer of pharmaceutical royalties, helping create the category as an investable asset class.
